BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mao YM, Zhao CN, Liu LN, Wu Q, Dan YL, Wang DG, Pan HF. Increased circulating interleukin-8 levels in systemic lupus erythematosus patients: a meta-analysis. Biomark Med 2018;12:1291-302. [PMID: 30511585 DOI: 10.2217/bmm-2018-0217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wakiya R, Ueeda K, Nakashima S, Shimada H, Kameda T, Mansour MMF, Kato M, Miyagi T, Sugihara K, Mizusaki M, Mino R, Kadowaki N, Dobashi H. Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus. Sci Rep 2022;12:10175. [PMID: 35715525 DOI: 10.1038/s41598-022-14571-6] [Reference Citation Analysis]
2 Liu T, Li J, Deng Z, Chen M, Sha K, Xiao W, Xie H, Zhao Z. Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity. J Dermatol 2022. [PMID: 35233832 DOI: 10.1111/1346-8138.16329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rajasundaram S, Rahman RP, Woolf B, Zhao SS, Gill D. Morning Cortisol and Circulating Inflammatory Cytokine Levels: A Mendelian Randomisation Study. Genes (Basel) 2022;13:116. [PMID: 35052454 DOI: 10.3390/genes13010116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kang P, Wu Z, Zhong Y, Wang Z, Zhou C, Huo S, Guo H, Li S, Xu K, Liu L, Chen S, Tang H, Wang H. A Network Pharmacology and Molecular Docking Strategy to Explore Potential Targets and Mechanisms Underlying the Effect of Curcumin on Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus. Biomed Res Int 2021;2021:5538643. [PMID: 34557547 DOI: 10.1155/2021/5538643] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Russell DA, Markiewicz M, Oates JC. Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells. Lupus Sci Med 2020;7:e000418. [PMID: 33037079 DOI: 10.1136/lupus-2020-000418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Menzel A, Samouda H, Dohet F, Loap S, Ellulu MS, Bohn T. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes? Antioxidants (Basel) 2021;10:414. [PMID: 33803155 DOI: 10.3390/antiox10030414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
7 Bergqvist F, Sundström Y, Shang MM, Gunnarsson I, Lundberg IE, Sundström M, Jakobsson PJ, Berg L. Anti-Inflammatory Properties of Chemical Probes in Human Whole Blood: Focus on Prostaglandin E2 Production. Front Pharmacol 2020;11:613. [PMID: 32435199 DOI: 10.3389/fphar.2020.00613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wu Q, Guan SY, Dan YL, Zhao CN, Mao YM, Liu LN, Li XM, Wang DG, Pan HF. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis. Biomark Med 2019;13:1417-27. [PMID: 31599644 DOI: 10.2217/bmm-2019-0161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]